Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-18-001090
Filing Date
2018-02-14
Accepted
2018-02-14 11:20:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 NOVELION THERAPEUTICS INC. p18-0445sc13ga.htm SC 13G/A 29330
  Complete submission text file 0000902664-18-001090.txt   31408
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43381 | Film No.: 18609023
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G/A